Systematic discovery of multicomponent therapeutics
Top Cited Papers
- 10 June 2003
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (13), 7977-7982
- https://doi.org/10.1073/pnas.1337088100
Abstract
Multicomponent therapies, originating through deliberate mixing of drugs in a clinical setting, through happenstance, and through rational design, have a successful history in a number of areas of medicine, including cancer, infectious diseases, and CNS disorders. We have developed a high-throughput screening method for identifying effective combinations of therapeutic compounds. We report here that systematic screening of combinations of small molecules reveals unexpected interactions between compounds, presumably due to interactions between the pathways on which they act. Through systematic screening of ≈120,000 different two-component combinations of reference-listed drugs, we identified potential multicomponent therapeutics, including (i) fungistatic and analgesic agents that together generate fungicidal activity in drug-resistant Candida albicans, yet do not significantly affect human cells, (ii) glucocorticoid and antiplatelet agents that together suppress the production of tumor necrosis factor-α in human primary peripheral blood mononu-clear cells, and (iii) antipsychotic and antiprotozoal agents that do not exhibit significant antitumor activity alone, yet together prevent the growth of tumors in mice. Systematic combination screening may ultimately be useful for exploring the connectivity of biological pathways and, when performed with reference-listed drugs, may result in the discovery of new combination drug regimens.Keywords
This publication has 45 references indexed in Scilit:
- Systems Biology: A Brief OverviewScience, 2002
- From HER2 to HerceptinCurrent Medical Research and Opinion, 2001
- From HER2 to HerceptinCurrent Medical Research and Opinion, 2001
- Inhibition of constitutive nitric oxide synthase in the brain by pentamidine, a calmodulin antagonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Dexamethasone and Cyclosporin A Suppress Mast Cell-Leukocyte Cytokine Cascades by Multiple MechanismsInternational Archives of Allergy and Immunology, 1995
- Inhibition of human monocyte TNF production by adenosine receptor agonistsLife Sciences, 1993
- Binding of Pt-pentamidine to nucleosomal DNA. Studies of the antiproliferative activity of the drug against human cancer cellsChemico-Biological Interactions, 1993
- Chlorpromazine-induced damage on nucleic acids: a combined cytogenetic and biochemical studyMutation Research, 1992
- Interferon response to dipyridamole in lupus erythematosus patientsBritish Journal of Dermatology, 1989
- Chlorpromazine: a potential anticancer agent?Biochemical and Biophysical Research Communications, 1984